Pilot study of budesonide inhalant suspension irrigations for chronic eosinophilic sinusitis

[...]previous works have indicated that patients are able to recall symptoms of smell accurately.8 The lack of a control group makes it difficult to determine what role a placebo effect and the natural course of the disease may have played. A lack of significance in the pilot data was likely driven...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of allergy and clinical immunology 2009-12, Vol.124 (6), p.1352-1354.e7
Hauptverfasser: Steinke, John W., PhD, Payne, Spencer C., MD, Tessier, M. Elizabeth, MD, Borish, Lori O., RN, Han, Joseph K., MD, Borish, Larry C., MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1354.e7
container_issue 6
container_start_page 1352
container_title Journal of allergy and clinical immunology
container_volume 124
creator Steinke, John W., PhD
Payne, Spencer C., MD
Tessier, M. Elizabeth, MD
Borish, Lori O., RN
Han, Joseph K., MD
Borish, Larry C., MD
description [...]previous works have indicated that patients are able to recall symptoms of smell accurately.8 The lack of a control group makes it difficult to determine what role a placebo effect and the natural course of the disease may have played. A lack of significance in the pilot data was likely driven by the inclusion of patients with well controlled asthma; however, 3 of 4 subjects who did not have controlled disease at baseline did show improvement.\n In addition, asthma control was determined using National Institutes of Health guidelines.E2 Each visual analogue scale (VAS) question was converted to a numerical value (0-6) to allow statistical analysis of symptoms before and after treatment (maximum sinus score for 16 symptoms, 96; maximum asthma score for 6 symptoms, 36).
doi_str_mv 10.1016/j.jaci.2009.09.018
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_876242203</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0091674909014067</els_id><sourcerecordid>734195621</sourcerecordid><originalsourceid>FETCH-LOGICAL-c495t-32ea1b6a0196f31c057aaa5802eedfba80fe4055ade578f0646182b2dc9e39d03</originalsourceid><addsrcrecordid>eNqFklGL1DAQx4Mo3t7pF_BBCj741HWStmkCIhyHnsKBgvomhDSZuqndZs20wn57U3bh4B4UBjLD_GaYyX8Ye8Fhy4HLN8N2sC5sBYDersbVI7bhoNtSKtE8Zpuc4KVsa33BLokGyHGl9FN2wbXmAKLdsB9fwhjngubFH4vYF93ikeIUPBZh2tnRTjm50AEnCnEqQkrhp52zS0UfU-F2KcOuwEhhioddGHOQ3YXCHOgZe9LbkfD5-b1i3z-8_3bzsbz7fPvp5vqudLVu5rISaHknLXAt-4o7aFprbaNAIPq-swp6rKFprMemVT3IWnIlOuGdxkp7qK7Y61PfQ4q_F6TZ7AM5HPP0GBcyqpWiFgKq_5JtVXPdSMEz-eoBOcQlTXkNwxuoFZdat5kSJ8qlSJSwN4cU9jYdDQezimQGs4pkVpHMalzlopfn1ku3R39fclYlA29PAOZP-xMwGXIBJ4c-JHSz8TH8u_-7B-VuDFklO_7CI9L9HoaEAfN1PZP1SkADr0G21V-taLig</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1504816997</pqid></control><display><type>article</type><title>Pilot study of budesonide inhalant suspension irrigations for chronic eosinophilic sinusitis</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Steinke, John W., PhD ; Payne, Spencer C., MD ; Tessier, M. Elizabeth, MD ; Borish, Lori O., RN ; Han, Joseph K., MD ; Borish, Larry C., MD</creator><creatorcontrib>Steinke, John W., PhD ; Payne, Spencer C., MD ; Tessier, M. Elizabeth, MD ; Borish, Lori O., RN ; Han, Joseph K., MD ; Borish, Larry C., MD</creatorcontrib><description>[...]previous works have indicated that patients are able to recall symptoms of smell accurately.8 The lack of a control group makes it difficult to determine what role a placebo effect and the natural course of the disease may have played. A lack of significance in the pilot data was likely driven by the inclusion of patients with well controlled asthma; however, 3 of 4 subjects who did not have controlled disease at baseline did show improvement.\n In addition, asthma control was determined using National Institutes of Health guidelines.E2 Each visual analogue scale (VAS) question was converted to a numerical value (0-6) to allow statistical analysis of symptoms before and after treatment (maximum sinus score for 16 symptoms, 96; maximum asthma score for 6 symptoms, 36).</description><identifier>ISSN: 0091-6749</identifier><identifier>EISSN: 1097-6825</identifier><identifier>DOI: 10.1016/j.jaci.2009.09.018</identifier><identifier>PMID: 19910027</identifier><language>eng</language><publisher>United States: Mosby, Inc</publisher><subject>Administration, Inhalation ; Allergies ; Allergy and Immunology ; Anti-Inflammatory Agents - administration &amp; dosage ; Anti-Inflammatory Agents - therapeutic use ; Aspirin ; Asthma ; Budesonide - administration &amp; dosage ; Budesonide - therapeutic use ; Chronic Disease ; Drug therapy ; Eosinophilia - drug therapy ; Eosinophils - drug effects ; Eosinophils - immunology ; Humans ; Medical imaging ; Pilot Projects ; Placebo effect ; Respiratory diseases ; Sinuses ; Sinusitis - drug therapy ; Statistical analysis</subject><ispartof>Journal of allergy and clinical immunology, 2009-12, Vol.124 (6), p.1352-1354.e7</ispartof><rights>American Academy of Allergy, Asthma &amp; Immunology</rights><rights>2009 American Academy of Allergy, Asthma &amp; Immunology</rights><rights>Copyright Elsevier Limited Dec 2009</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c495t-32ea1b6a0196f31c057aaa5802eedfba80fe4055ade578f0646182b2dc9e39d03</citedby><cites>FETCH-LOGICAL-c495t-32ea1b6a0196f31c057aaa5802eedfba80fe4055ade578f0646182b2dc9e39d03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jaci.2009.09.018$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,27923,27924,45994</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19910027$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Steinke, John W., PhD</creatorcontrib><creatorcontrib>Payne, Spencer C., MD</creatorcontrib><creatorcontrib>Tessier, M. Elizabeth, MD</creatorcontrib><creatorcontrib>Borish, Lori O., RN</creatorcontrib><creatorcontrib>Han, Joseph K., MD</creatorcontrib><creatorcontrib>Borish, Larry C., MD</creatorcontrib><title>Pilot study of budesonide inhalant suspension irrigations for chronic eosinophilic sinusitis</title><title>Journal of allergy and clinical immunology</title><addtitle>J Allergy Clin Immunol</addtitle><description>[...]previous works have indicated that patients are able to recall symptoms of smell accurately.8 The lack of a control group makes it difficult to determine what role a placebo effect and the natural course of the disease may have played. A lack of significance in the pilot data was likely driven by the inclusion of patients with well controlled asthma; however, 3 of 4 subjects who did not have controlled disease at baseline did show improvement.\n In addition, asthma control was determined using National Institutes of Health guidelines.E2 Each visual analogue scale (VAS) question was converted to a numerical value (0-6) to allow statistical analysis of symptoms before and after treatment (maximum sinus score for 16 symptoms, 96; maximum asthma score for 6 symptoms, 36).</description><subject>Administration, Inhalation</subject><subject>Allergies</subject><subject>Allergy and Immunology</subject><subject>Anti-Inflammatory Agents - administration &amp; dosage</subject><subject>Anti-Inflammatory Agents - therapeutic use</subject><subject>Aspirin</subject><subject>Asthma</subject><subject>Budesonide - administration &amp; dosage</subject><subject>Budesonide - therapeutic use</subject><subject>Chronic Disease</subject><subject>Drug therapy</subject><subject>Eosinophilia - drug therapy</subject><subject>Eosinophils - drug effects</subject><subject>Eosinophils - immunology</subject><subject>Humans</subject><subject>Medical imaging</subject><subject>Pilot Projects</subject><subject>Placebo effect</subject><subject>Respiratory diseases</subject><subject>Sinuses</subject><subject>Sinusitis - drug therapy</subject><subject>Statistical analysis</subject><issn>0091-6749</issn><issn>1097-6825</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFklGL1DAQx4Mo3t7pF_BBCj741HWStmkCIhyHnsKBgvomhDSZuqndZs20wn57U3bh4B4UBjLD_GaYyX8Ye8Fhy4HLN8N2sC5sBYDersbVI7bhoNtSKtE8Zpuc4KVsa33BLokGyHGl9FN2wbXmAKLdsB9fwhjngubFH4vYF93ikeIUPBZh2tnRTjm50AEnCnEqQkrhp52zS0UfU-F2KcOuwEhhioddGHOQ3YXCHOgZe9LbkfD5-b1i3z-8_3bzsbz7fPvp5vqudLVu5rISaHknLXAt-4o7aFprbaNAIPq-swp6rKFprMemVT3IWnIlOuGdxkp7qK7Y61PfQ4q_F6TZ7AM5HPP0GBcyqpWiFgKq_5JtVXPdSMEz-eoBOcQlTXkNwxuoFZdat5kSJ8qlSJSwN4cU9jYdDQezimQGs4pkVpHMalzlopfn1ku3R39fclYlA29PAOZP-xMwGXIBJ4c-JHSz8TH8u_-7B-VuDFklO_7CI9L9HoaEAfN1PZP1SkADr0G21V-taLig</recordid><startdate>20091201</startdate><enddate>20091201</enddate><creator>Steinke, John W., PhD</creator><creator>Payne, Spencer C., MD</creator><creator>Tessier, M. Elizabeth, MD</creator><creator>Borish, Lori O., RN</creator><creator>Han, Joseph K., MD</creator><creator>Borish, Larry C., MD</creator><general>Mosby, Inc</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7SS</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20091201</creationdate><title>Pilot study of budesonide inhalant suspension irrigations for chronic eosinophilic sinusitis</title><author>Steinke, John W., PhD ; Payne, Spencer C., MD ; Tessier, M. Elizabeth, MD ; Borish, Lori O., RN ; Han, Joseph K., MD ; Borish, Larry C., MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c495t-32ea1b6a0196f31c057aaa5802eedfba80fe4055ade578f0646182b2dc9e39d03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Administration, Inhalation</topic><topic>Allergies</topic><topic>Allergy and Immunology</topic><topic>Anti-Inflammatory Agents - administration &amp; dosage</topic><topic>Anti-Inflammatory Agents - therapeutic use</topic><topic>Aspirin</topic><topic>Asthma</topic><topic>Budesonide - administration &amp; dosage</topic><topic>Budesonide - therapeutic use</topic><topic>Chronic Disease</topic><topic>Drug therapy</topic><topic>Eosinophilia - drug therapy</topic><topic>Eosinophils - drug effects</topic><topic>Eosinophils - immunology</topic><topic>Humans</topic><topic>Medical imaging</topic><topic>Pilot Projects</topic><topic>Placebo effect</topic><topic>Respiratory diseases</topic><topic>Sinuses</topic><topic>Sinusitis - drug therapy</topic><topic>Statistical analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Steinke, John W., PhD</creatorcontrib><creatorcontrib>Payne, Spencer C., MD</creatorcontrib><creatorcontrib>Tessier, M. Elizabeth, MD</creatorcontrib><creatorcontrib>Borish, Lori O., RN</creatorcontrib><creatorcontrib>Han, Joseph K., MD</creatorcontrib><creatorcontrib>Borish, Larry C., MD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of allergy and clinical immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Steinke, John W., PhD</au><au>Payne, Spencer C., MD</au><au>Tessier, M. Elizabeth, MD</au><au>Borish, Lori O., RN</au><au>Han, Joseph K., MD</au><au>Borish, Larry C., MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pilot study of budesonide inhalant suspension irrigations for chronic eosinophilic sinusitis</atitle><jtitle>Journal of allergy and clinical immunology</jtitle><addtitle>J Allergy Clin Immunol</addtitle><date>2009-12-01</date><risdate>2009</risdate><volume>124</volume><issue>6</issue><spage>1352</spage><epage>1354.e7</epage><pages>1352-1354.e7</pages><issn>0091-6749</issn><eissn>1097-6825</eissn><abstract>[...]previous works have indicated that patients are able to recall symptoms of smell accurately.8 The lack of a control group makes it difficult to determine what role a placebo effect and the natural course of the disease may have played. A lack of significance in the pilot data was likely driven by the inclusion of patients with well controlled asthma; however, 3 of 4 subjects who did not have controlled disease at baseline did show improvement.\n In addition, asthma control was determined using National Institutes of Health guidelines.E2 Each visual analogue scale (VAS) question was converted to a numerical value (0-6) to allow statistical analysis of symptoms before and after treatment (maximum sinus score for 16 symptoms, 96; maximum asthma score for 6 symptoms, 36).</abstract><cop>United States</cop><pub>Mosby, Inc</pub><pmid>19910027</pmid><doi>10.1016/j.jaci.2009.09.018</doi></addata></record>
fulltext fulltext
identifier ISSN: 0091-6749
ispartof Journal of allergy and clinical immunology, 2009-12, Vol.124 (6), p.1352-1354.e7
issn 0091-6749
1097-6825
language eng
recordid cdi_proquest_miscellaneous_876242203
source MEDLINE; ScienceDirect Journals (5 years ago - present); EZB-FREE-00999 freely available EZB journals
subjects Administration, Inhalation
Allergies
Allergy and Immunology
Anti-Inflammatory Agents - administration & dosage
Anti-Inflammatory Agents - therapeutic use
Aspirin
Asthma
Budesonide - administration & dosage
Budesonide - therapeutic use
Chronic Disease
Drug therapy
Eosinophilia - drug therapy
Eosinophils - drug effects
Eosinophils - immunology
Humans
Medical imaging
Pilot Projects
Placebo effect
Respiratory diseases
Sinuses
Sinusitis - drug therapy
Statistical analysis
title Pilot study of budesonide inhalant suspension irrigations for chronic eosinophilic sinusitis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T10%3A29%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pilot%20study%20of%20budesonide%20inhalant%20suspension%20irrigations%20for%20chronic%20eosinophilic%20sinusitis&rft.jtitle=Journal%20of%20allergy%20and%20clinical%20immunology&rft.au=Steinke,%20John%20W.,%20PhD&rft.date=2009-12-01&rft.volume=124&rft.issue=6&rft.spage=1352&rft.epage=1354.e7&rft.pages=1352-1354.e7&rft.issn=0091-6749&rft.eissn=1097-6825&rft_id=info:doi/10.1016/j.jaci.2009.09.018&rft_dat=%3Cproquest_cross%3E734195621%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1504816997&rft_id=info:pmid/19910027&rft_els_id=S0091674909014067&rfr_iscdi=true